ENEST1st Subset Analysis: Impact of Age on Efficacy and Toxicity of Nilotinib in Chronic-Phase CML


ENEST1st Subset Analysis: Impact of Age on Efficacy and Toxicity of Nilotinib in Chronic-Phase CML
Slides from a presentation at ASH 2015

Giles FJ et al. Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase (CML-CP): ENEST1st sub-analysis. Proc ASH 2015;Abstract 479.